{"id":"W1145000572","doi":"10.1097/spc.0000000000000158","title":"Options in metastatic urothelial cancer after first-line therapy","year":2015,"lang":"en","type":"review","venue":"Current Opinion in Supportive and Palliative Care","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Metastatic Urothelial Carcinoma; Cabozantinib; Oncology; Disease; Targeted therapy; Internal medicine; Optimism; Urothelial carcinoma; Bladder cancer; Precision medicine; Chemotherapy; Cancer; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004970358,0.0006666895,0.001369412,0.001805291,0.0002411601,0.0008853834,0.0006730607,0.0008439011,0.003651337],"category_scores_gemma":[0.001079915,0.0001657503,0.0005386632,0.001609241,0.0003929416,0.001145399,0.0005262478,0.001247668,0.001225778],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004692256,"about_ca_system_score_gemma":0.00120098,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007977407,"about_ca_topic_score_gemma":0.001690375,"domain_scores_codex":[0.9997873,0.00004934685,0.00004300998,0.00003260427,0.00007200674,0.00001577947],"domain_scores_gemma":[0.9995258,0.0002576725,0.0000994416,0.000009814253,0.00008156925,0.00002568184],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00006781782,0.00004022409,0.0002114822,0.05375625,0.0001226484,0.0003598814,0.00008349343,0.0004056328,0.0007878296,0.002718808,0.03642179,0.9050241],"study_design_scores_gemma":[0.00001787878,0.00009172928,0.0009836297,0.01941673,0.0002070237,0.003510677,0.0001023102,0.00009920353,0.0003223658,0.00170651,0.9735234,0.00001841659],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00005588832,0.9991832,0.0000409039,0.0001809659,0.0001355296,0.000002545187,0.000008833629,0.000002601167,0.0003895464],"genre_scores_gemma":[0.0004450465,0.9990527,0.00005574837,0.000142261,0.0001333766,0.000002764358,0.0000159321,7.111493e-7,0.000151525],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003651337,"threshold_uncertainty_score":0.01221496,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2667728493851469,"score_gpt":0.4894585351172422,"score_spread":0.2226856857320953,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}